Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.167 EUR | +67.00% |
|
-.--% | -30.42% |
Jun. 28 | Redx Pharma Plc Reports Encouraging Zamaporvint Phase 2 Combination Data in MSS mCRC at ESMO GI Congress | CI |
Jun. 20 | Redx to Present Zamaporvint Phase2 Data At Esmo Gi | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
70.6M | - | - | - | - | - | |
126B | ||||||
118B | ||||||
27.87B | - | |||||
20.95B | - | |||||
16.92B |
- Stock Market
- Equities
- 0RX Stock
- Charts Redx Pharma Plc
- Sector Chart